Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$203.1MMiss by $2.2M
EPS$0.09Miss by $0.01
Revenue estimate$205.3M
EPS estimate$0.10

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$193.2M
EPS estimate$0.08

Financials

Q2 2025

Income statement

See full
Revenue$203.1M+1.2%
Gross profit$189.7M+0.5%
Operating income$26.8M+34.9%
Net income$12.8M+91.9%
EPS (diluted)$0.04+100%

Balance sheet

See full
Cash & equivalents$281.3M-46.4%
Total debt$547.5M-22.6%
Total equity$643.0M-3.9%
Total assets$1.3B-10.6%

Cash flow

See full
Operating cash flow$49.6M+411%
CapEx$390.0K+45.5%
Free cash flow$49.2M+421%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.81B-40.5%
Enterprise value$2.08B-35.6%
P/E52.3×—
P/S2.3×-1.7×

Profitability

See full
Gross margin93.7%+1.2pp
Operating margin11.1%+8.8pp
Net margin4.3%+2.6pp
FCF margin23.7%+7.3pp

Returns & leverage

See full
Return on equity5.3%+3.3pp
Debt / equity0.9×-0.2×
Current ratio4.2×-3.1×

Segments

By product

See full
Prescription transactions revenue$143.1M-2.5%
Pharma Direct revenue$35.0M+32.0%
Subscription revenue$20.5M-6.8%
Other revenue$4.6M-15.6%

Versus estimates

Revenue

Q1 2026$194.0MBeat by $8.6MQ4 2025$194.8MBeat by $1.5MQ3 2025$196.0MBeat by $2.8M
Q2 2025$203.1MMiss by $2.2M
Q1 2025$203.0MBeat by $767.5KQ4 2024$198.6MMiss by $1.1M

Diluted EPS

Q1 2026$0.07In lineQ4 2025$0.09In lineQ3 2025$0.08Miss by $0.01
Q2 2025$0.09Miss by $0.01
Q1 2025$0.09In lineQ4 2024$0.09Miss by $0.01

Ask the moment GoodRx Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did GoodRx Holdings, Inc. report Q2 2025 earnings?
GoodRx Holdings, Inc. (GDRX) reported Q2 2025 earnings on August 6, 2025 after market close.
What were GoodRx Holdings, Inc.'s Q2 2025 revenue and EPS?
GoodRx Holdings, Inc. reported revenue of $203.1M and eps of $0.09 for Q2 2025.
Did GoodRx Holdings, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $205.3M by $2.2M. EPS missed the consensus estimate of $0.10 by $0.01.
How did GoodRx Holdings, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.2% from $200.6M a year earlier and eps grew 12.5% from $0.08.
Where can I find GoodRx Holdings, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001809519-25-000117) directly on SEC EDGAR. The filing index links above go to sec.gov.